This is an open-label, single-center, phase 1 study designed to evaluate the pharmacokinetics in healthy adult participants after single and multiple subcutaneous injections of pegilodecakin.
To evaluate the pharmacokinetics of single and multiple doses of pegilodecakin in healthy participants.